California California Franchise Tax Board [Member] Future Minimum Lease Payments Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity [Abstract] Options vested or expected to vest, weighted average remaining contractual term (in years) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term Adjustments to reconcile net loss to net cash used in operating activities: Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Statistical Measurement [Domain] Statistical Measurement [Domain] Gross Unrealized Losses Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax U.S. Federal benefit at statutory rate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount Cover [Abstract] Cover [Abstract] Net decrease in cash and cash equivalents Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Schedule of Future Minimum Lease Payments Under Lease Agreements Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block] Sale of New Jersey State NOLs Effective Income Tax Rate Reconciliation, Sale Of State Net Operating Losses Effective Income Tax Rate Reconciliation, Sale Of State Net Operating Losses Income Tax Jurisdiction [Domain] Income Tax Jurisdiction [Domain] Trading Symbol Trading Symbol Ownership percentage Equity Method Investment, Ownership Percentage Comprehensive loss Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest All Trading Arrangements All Trading Arrangements [Member] Maximum annual contribution per employee Employee Stock Purchase Plan, Maximum Annual Contribution Per Employee Employee Stock Purchase Plan, Maximum Annual Contribution Per Employee Compensation Actually Paid vs. Net Income Compensation Actually Paid vs. Net Income [Text Block] Non-NEOs Non-NEOs [Member] Vesting terms (in years) Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period Tax credit carryforward Tax Credit Carryforward, Amount Rule 10b5-1 Arrangement Adopted Rule 10b5-1 Arrangement Adopted [Flag] Awards Close in Time to MNPI Disclosures Awards Close in Time to MNPI Disclosures [Table] Forfeited (in shares) Warrants Canceled, Shares Warrants Canceled, Shares Pay vs Performance Disclosure [Line Items] Peer Group Total Shareholder Return Amount Peer Group Total Shareholder Return Amount Accounts receivable Increase (Decrease) in Accounts Receivable Long-lived Assets Property, Plant and Equipment, Impairment [Policy Text Block] Loss Per Share Earnings Per Share, Policy [Policy Text Block] Non-Rule 10b5-1 Arrangement Adopted Non-Rule 10b5-1 Arrangement Adopted [Flag] Deferred Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract] Fair Value Measurements Fair Value Disclosures [Text Block] Proceeds from exercise of options Proceeds from Stock Options Exercised Available for sale securities - net unrealized gain OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax Award Timing Disclosures [Line Items] Investment, Name [Domain] Investment, Name [Domain] Warrants exercisable (in dollars per share) Weighted Average Exercise Price, Warrants Exercisable Weighted Average Exercise Price, Warrants Exercisable Other Performance Measure, Amount Other Performance Measure, Amount Research Tax Credit Carryforward Research Tax Credit Carryforward [Member] Amortization expense, year three Finite-Lived Intangible Asset, Expected Amortization, Year Three Total Income Tax Expense (Benefit), Continuing Operations, by Jurisdiction [Abstract] Operating Leases Lessee, Operating Leases [Text Block] Common stock, shares, outstanding (in shares) Beginning Balance (in shares) Ending Balance (in shares) Common Stock, Shares, Outstanding Clinical department Clinical Department [Member] Clinical Department Documents Incorporated by Reference Documents Incorporated by Reference [Text Block] Termination of contract, lapse of payment Termination of Contract, Lapse of Payment Termination of Contract, Lapse of Payment Operating lease liabilities, noncurrent, balance sheet line item Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration] Sales of marketable securities Proceeds from Sale and Maturity of Marketable Securities Number of shares available for future grant (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant Other long-term liabilities Operating Lease, Liability, Noncurrent Annual license maintenance fee Collaborative Arrangement, Rights and Obligations, Annual License Maintenance Fee Collaborative Arrangement, Rights and Obligations, Annual License Maintenance Fee Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] Segment Information Segment Reporting, Policy [Policy Text Block] U.S. Federal Federal Income Tax Expense (Benefit), Continuing Operations Plan Name [Domain] Plan Name [Domain] Other assets Other Assets, Noncurrent Entity Tax Identification Number Entity Tax Identification Number Leases [Abstract] Leases [Abstract] BOLSTER trial Bolster Trial [Member] Bolster Trial Additions based on tax positions related to the prior years Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions Antidilutive Securities, Name [Domain] Antidilutive Securities, Name [Domain] Money market funds Money Market Funds [Member] Option to terminate Research Collaboration and License Agreement, Option to Terminate Research Collaboration and License Agreement, Option to Terminate Net cash used in operating activities Net Cash Provided by (Used in) Operating Activities Cash flows from operating activities: Net Cash Provided by (Used in) Operating Activities [Abstract] Treasury Stock Treasury Stock, Common [Member] Fair market value of tax NOLs Fair Market Value of Tax NOLs Fair Market Value of Tax NOLs Accumulated depreciation Deferred Tax Assets, Property, Plant and Equipment Plan Name [Axis] Plan Name [Axis] Statement, Equity Components [Axis] Equity Components [Axis] Lingmed Limited Lingmed Limited [Member] Lingmed Limited Share-based Compensation [Line Items] Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] Award Timing Method Award Timing Method [Text Block] Research and Development Costs Research and Development Expense, Policy [Policy Text Block] Trading Arrangements, by Individual Trading Arrangements, by Individual [Table] Options, exercisable (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price Estimated Fair Value Total Debt Securities, Available-for-Sale Accounts Receivable Accounts Receivable [Policy Text Block] Measurement Frequency [Axis] Measurement Frequency [Axis] Sublicensing fee Collaborative Arrangement, Rights and Obligations, Sublicensing Fees Collaborative Arrangement, Rights and Obligations, Sublicensing Fees Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Insider Trading Policies and Procedures [Line Items] 2012 ESPP Employee Stock Purchase Plan 2012 [Member] Employee Stock Purchase Plan 2012 [Member] Municipal debt securities US States and Political Subdivisions Debt Securities [Member] Use of Estimates Use of Estimates, Policy [Policy Text Block] Adjustment to Compensation, Amount Adjustment to Compensation Amount Options outstanding, aggregate intrinsic value Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value Compensation Amount Outstanding Recovery Compensation Amount 2018 Plan Equity Incentive Compensation Plan 2018 [Member] Equity Incentive Compensation Plan 2018 [Member] Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member] Entity Small Business Entity Small Business Accrued Liabilities Accounts Payable and Accrued Liabilities Disclosure [Text Block] Company Selected Measure Amount Company Selected Measure Amount Tabular List, Table Tabular List [Table Text Block] Net deferred tax asset Deferred Tax Assets, Net Level 3 Fair Value, Inputs, Level 3 [Member] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member] Shares issued under ESPP (in shares) Stock Issued During Period, Shares, Employee Stock Purchase Plans Debt Securities, Available-for-sale [Line Items] Debt Securities, Available-for-Sale [Line Items] Accrued liabilities Accrued liabilities Accrued Liabilities, Current Anti-dilutive securities excluded from computation of loss per share (in shares) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Share-based award tranche one Share-Based Payment Arrangement, Tranche One [Member] Cash and cash equivalents at beginning of year Cash and cash equivalents at end of year Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents Warrants exercisable, aggregate intrinsic value Aggregate Intrinsic Value, Warrants Vested Aggregate Intrinsic Value, Warrants Vested Exercised (in dollars per share) Weighted Average Exercise Price, Warrants Exercised Weighted Average Exercise Price, Warrants Exercised Amortization/accretion on marketable securities Accretion (Amortization) of Discounts and Premiums, Investments Unrecognized compensation cost Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount Current Assets Assets, Current [Abstract] Consolidation Items [Axis] Consolidation Items [Axis] Allowance for credit loss Accounts Receivable, Allowance for Credit Loss Tax withholding payments on net share settlement equity awards Payment, Tax Withholding, Share-Based Payment Arrangement Other comprehensive income (loss): Other Comprehensive Income (Loss), Net of Tax [Abstract] Income tax refunds Proceeds from Income Tax Refunds 2017 ESPP Employee Stock Purchase Plan 2017 [Member] Employee Stock Purchase Plan 2017 [Member] SAFE, valuation cap SAFE, Valuation Cap SAFE, Valuation Cap Treasury stock (in shares) Treasury Stock, Common, Shares Collaborative Arrangement Transaction Statement Of Income Or Comprehensive Income Extensible Enumeration Not Disclosed Flag Collaborative Arrangement Transaction Statement Of Income Or Comprehensive Income Extensible Enumeration Not Disclosed Flag Collaborative Arrangement Transaction Statement Of Income Or Comprehensive Income Extensible Enumeration Not Disclosed Flag Forgone Recovery due to Disqualification of Tax Benefits, Amount Forgone Recovery due to Disqualification of Tax Benefits, Amount Product and Service [Domain] Product and Service [Domain] Stock options Stock options Share-Based Payment Arrangement, Option [Member] Debt Securities, Available-for-sale [Table] Debt Securities, Available-for-Sale [Table] Vested, Weighted average grant date fair value (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value Depreciation expense Depreciation Fair Value Disclosures [Abstract] Fair Value Disclosures [Abstract] 2025 Lessee, Operating Lease, Liability, to be Paid, Year One License License [Member] Antidilutive Security, Excluded EPS Calculation [Table] Antidilutive Security, Excluded EPS Calculation [Table] Comprehensive loss attributable to Lisata Therapeutics, Inc. common stockholders Comprehensive Income (Loss), Net of Tax, Attributable to Parent Cash and marketable securities Cash, Cash Equivalents, and Marketable Securities Cash, Cash Equivalents, and Marketable Securities Warrants Warrant [Member] Security Exchange Name Security Exchange Name Schedule of Available-for-Sale Securities by Contractual Maturity Investments Classified by Contractual Maturity Date [Table Text Block] Award Type [Axis] Award Type [Axis] Corporate debt securities Corporate Debt Securities [Member] Income Tax, Holiday [Table] Income Tax, Holiday [Table] Exercised (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Warrants, Shares Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] Property and equipment, net Property and equipment, net Property, Plant and Equipment, Net ICFR Auditor Attestation Flag ICFR Auditor Attestation Flag State and local Current State and Local Tax Expense (Benefit) Total liabilities Liabilities Non-controlling interests Equity, Attributable to Noncontrolling Interest Amount available for sale Sale of Stock Available for Sale Sale of Stock Available for Sale Accounts payable, accrued liabilities and other liabilities Increase Decrease In Accounts Payable Accrued Expenses And Other Liabilities Increase Decrease In Accounts Payable Accrued Expenses And Other Liabilities Common stock, par value (in dollars per share) Common Stock, Par or Stated Value Per Share Forgone Recovery, Explanation of Impracticability Forgone Recovery, Explanation of Impracticability [Text Block] Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Foreign Currency Remeasurement Foreign Currency Transactions and Translations Policy [Policy Text Block] Expiration Date Trading Arrangement Expiration Date Right-of-Use Assets: Operating Lease, Right-Of-Use Asset [Abstract] Operating Lease, Right-Of-Use Asset Cash flows from investing activities: Net Cash Provided by (Used in) Investing Activities [Abstract] Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward] Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward] Investment owned (in shares) Investment Owned, Balance, Shares Operating lease liabilities - current Accrued liabilities Operating Lease, Liability, Current Total Shareholder Return Amount Total Shareholder Return Amount Common stock, shares, issued (in shares) Common Stock, Shares, Issued Effective Income Tax Rate Reconciliation, Amount [Abstract] Income Tax Expense (Benefit), Effective Income Tax Rate Reconciliation, Amount [Abstract] Aggregate offering amount authorized per agreement Sale Of Stock, Aggregate Offering Amount Authorized Per Agreement Sale Of Stock, Aggregate Offering Amount Authorized Per Agreement Schedule of Restricted Stock Nonvested Restricted Stock Shares Activity [Table Text Block] Entity [Domain] Entity [Domain] Equity Awards Adjustments, Footnote Equity Awards Adjustments, Footnote [Text Block] Accumulated net operating losses (tax effected) Deferred Tax Assets, Operating Loss Carryforwards Computer equipment Computer Equipment [Member] Insider Trading Policies and Procedures Adopted Insider Trading Policies and Procedures Adopted [Flag] Accumulated depreciation Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Subsequent Event [Line Items] Subsequent Event [Line Items] Property and equipment, gross Property, Plant and Equipment, Gross Proceeds from option exercises (in shares) Exercised (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period Schedule of Operating Lease Liabilities and Right-of-Use Assets on Balance Sheet Lessee, Operating Lease, Balance Sheet Presentation [Table Text Block] Lessee, Operating Lease, Balance Sheet Presentation [Table Text Block] Named Executive Officers, Footnote Named Executive Officers, Footnote [Text Block] Research and development Research and Development Expense [Member] Warrants vested or expected to vest (in shares) Vested and Expected to Vest, Shares Vested and Expected to Vest, Shares Stock Options, Weighted Average Exercise Price Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract] Reductions due to lapse in statute of limitations and settlements Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations Common stock, shares authorized (in shares) Common Stock, Shares Authorized Warrants, Weighted Average Exercise Price Warrants Weighted Average Exercise Price [Roll Forward] Warrants Weighted Average Exercise Price [Roll Forward] Basis of Presentation Basis of Accounting, Policy [Policy Text Block] Unrealized gain on marketable securities OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax Diluted (in shares) Weighted Average Number of Shares Outstanding, Diluted Technology Transfer Agreement Technology Transfer Agreement [Text Block] Technology Transfer Agreement Intangibles Deferred Tax Assets, Goodwill and Intangible Assets Outstanding stock threshold Outstanding Stock Threshold Outstanding Stock Threshold MNPI Disclosure Timed for Compensation Value MNPI Disclosure Timed for Compensation Value [Flag] Total Lisata Therapeutics, Inc. stockholders' equity Equity, Attributable to Parent Deferred tax assets Deferred Tax Assets, Gross Entity Voluntary Filers Entity Voluntary Filers Operating Lease Liabilities: Operating Lease, Liability [Abstract] License Agreements Research Collaboration and License Agreement Collaborative Arrangement Disclosure [Text Block] Less than one year Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One Litigation settlement, future milestone payments Litigation Settlement, Future Milestone Payments, Percent Litigation Settlement, Future Milestone Payments, Percent Litigation Case [Axis] Litigation Case [Axis] Percentage held by non-affiliates Sale of Stock Available for Sale, Percentage Sale of Stock Available for Sale, Percentage Total deferred income tax provision (benefit) Deferred Income Tax Expense (Benefit) Property and Equipment Property, Plant and Equipment Disclosure [Text Block] Investment income, net Investment Income, Net Sanford Burnham Prebys Sanford Burnham Prebys [Member] Sanford Burnham Prebys Recurring Fair Value, Recurring [Member] Accounts receivable Accounts Receivable, after Allowance for Credit Loss, Current Granted (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross Investments in and Advances to Affiliates [Line Items] Investments in and Advances to Affiliates [Line Items] Forfeited (in dollars per share) Weighted Average Exercise Price, Warrants Canceled Weighted Average Exercise Price, Warrants Canceled Number of shares authorized for issuance (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized Sale of Stock, Name of Transaction [Domain] Sale of Stock [Domain] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Pension Adjustments Prior Service Cost Pension Adjustments Prior Service Cost [Member] Document Fiscal Period Focus Document Fiscal Period Focus Warrants, Weighted Average Contractual Term and Intrinsic Value Warrants Other Disclosures [Abstract] Warrants Other Disclosures [Abstract] All Executive Categories All Executive Categories [Member] Amortization expense, year two Finite-Lived Intangible Asset, Expected Amortization, Year Two Changed Peer Group, Footnote Changed Peer Group, Footnote [Text Block] Options outstanding, weighted average remaining contractual term (in years) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term ASSETS Assets [Abstract] Total other comprehensive loss Other Comprehensive Income (Loss), Net of Tax Expected dividend yield Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate Document Type Document Type Value of stock issued Stock Issued During Period, Value, Restricted Stock Award, Gross Commercial Paper Commercial Paper [Member] Pension Benefits Adjustments, Footnote Pension Benefits Adjustments, Footnote [Text Block] Schedule of Segment Reporting Information, by Segment Schedule of Segment Reporting Information, by Segment [Table Text Block] Total Shareholder Return Vs Peer Group Total Shareholder Return Vs Peer Group [Text Block] Number of stock issued (in shares) Stock Issued During Period, Shares, Restricted Stock Award, Gross Software Computer Software, Intangible Asset [Member] Document Annual Report Document Annual Report CEND CEND [Member] CEND Purchase of marketable securities Payments to Acquire Marketable Securities Shares modified (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Shares Modified Share-Based Compensation Arrangement by Share-Based Payment Award, Shares Modified Vested (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period Cost Debt Securities, Available-for-Sale, Amortized Cost Litigation settlement, first milestone payment Litigation Settlement, Milestone Payment Litigation Settlement, Milestone Payment Total Lisata Therapeutics, Inc. Stockholders' Equity Parent [Member] Schedule of Fair Value of Shares Vested and Weighted Average Estimated Fair Values of Shares Granted Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value [Table Text Block] Subsequent Event [Table] Subsequent Event [Table] Maximum Maximum [Member] Amortization of intangible assets Amortization of Intangible Assets Upfront payment Contract with Customer, Liability Equity Valuation Assumption Difference, Footnote Equity Valuation Assumption Difference, Footnote [Text Block] Furniture and fixtures Furniture and Fixtures [Member] Acquired license-intangible, net Finite-Lived Intangible Assets, Net Antidilutive Securities [Axis] Antidilutive Securities [Axis] Accounts payable Accounts Payable, Current Accounting Policies [Abstract] Accounting Policies [Abstract] Liabilities Liabilities [Abstract] Leasehold improvements Leasehold Improvements [Member] Expired (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price Schedule of Assumptions in Calculating Fair Values of Stock Options Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Current Fiscal Year End Date Current Fiscal Year End Date Less: Amounts representing interest Lessee, Operating Lease, Liability, Undiscounted Excess Amount Statistical Measurement [Axis] Statistical Measurement [Axis] PEO Name PEO Name Collaborative Arrangement, Transaction with Party to Collaborative Arrangement Collaborative Arrangement, Transaction with Party to Collaborative Arrangement [Member] Non-Rule 10b5-1 Arrangement Terminated Non-Rule 10b5-1 Arrangement Terminated [Flag] Net loss before benefit from income taxes and noncontrolling interests Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Shares held by third party (in shares) Shares Held by Third Party Shares Held by Third Party Non-PEO NEO Average Total Compensation Amount Non-PEO NEO Average Total Compensation Amount Vesting [Axis] Vesting [Axis] Award Type [Domain] Award Type [Domain] Name Outstanding Recovery, Individual Name Disaggregation of Revenue [Line Items] Disaggregation of Revenue [Line Items] Share-based compensation (in shares) Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture Chemistry, manufacturing and controls Chemistry Manufacturing And Controls [Member] Chemistry Manufacturing And Controls Share-based compensation Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-Based Compensation Cost Schedule of Antidilutive Securities Excluded from Computation of Loss Per Share Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Compensation Actually Paid vs. Company Selected Measure Compensation Actually Paid vs. Company Selected Measure [Text Block] Non-PEO NEO Non-PEO NEO [Member] Intangible asset, useful life Finite-Lived Intangible Asset, Useful Life Marketable securities - available for sale Investments, Fair Value Disclosure Additional Paid-in Capital Additional Paid-in Capital [Member] Award Timing Predetermined Award Timing Predetermined [Flag] Subsequent Event Type [Domain] Subsequent Event Type [Domain] Investment, Name [Axis] Investment, Name [Axis] Recently issued accounting pronouncements not yet adopted/ Recently adopted accounting pronouncements New Accounting Pronouncements, Policy [Policy Text Block] Other Other General and Administrative Expense Lisata Therapeutics, Inc. common stockholders - diluted (in dollars per share) Earnings Per Share, Diluted Counterparty Name [Domain] Counterparty Name [Domain] Revenue Recognition Revenue from Contract with Customer [Policy Text Block] Name Measure Name State State and Local Jurisdiction [Member] United States Income (Loss) from Continuing Operations before Income Taxes, Domestic Warrants vested or expected to vest, weighted average remaining contractual term (in years) Weighted Average Remaining Contractual Term, Warrants Vested and Expect to Vest Weighted Average Remaining Contractual Term, Warrants Vested and Expect to Vest Entity Interactive Data Current Entity Interactive Data Current Total current income tax provision (benefit) Current Income Tax Expense (Benefit) Restatement does not require Recovery Restatement Does Not Require Recovery [Text Block] Options exercisable, weighted average remaining contractual term (in years) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term Total Cash, Cash Equivalents, and Short-Term Investments Intangible Asset Intangible Assets, Finite-Lived, Policy [Policy Text Block] Number of operating segments Number of Operating Segments Preferred stock, shares issued (in shares) Preferred Stock, Shares Issued Deferred Tax Liabilities: Deferred Tax Liabilities, Gross [Abstract] Disaggregation of Revenue [Table] Disaggregation of Revenue [Table] Statement of Financial Position [Abstract] Statement of Financial Position [Abstract] Proceeds from sale of NOLs, gross Proceeds From Sale Of Net Operating Losses, Gross Proceeds From Sale Of Net Operating Losses, Gross Treasury bills US Treasury Bill Securities [Member] Share-based compensation expense Share-Based Payment Arrangement, Noncash Expense Net deferred tax asset Deferred Tax Assets, Net of Valuation Allowance Right-of-use asset Deferred Tax Liabilities, Operating Lease, Right- of-Use Asset Deferred Tax Liabilities, Operating Lease, Right- of-Use Asset Warrants vested or expected to vest (in dollars per share) Weighted Average Exercise Price, Warrants Vested And Expected To Vest Weighted Average Exercise Price, Warrants Vested And Expected To Vest Net loss Net loss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Share-based award tranche two Share-Based Payment Arrangement, Tranche Two [Member] Benefit from income taxes Tax benefit Income Tax Expense (Benefit) Other income (expense): Nonoperating Income (Expense) [Abstract] Royalties, net of sales Collaborative Arrangement, Rights and Obligations, Royalties Net of Sales Collaborative Arrangement, Rights and Obligations, Royalties Net of Sales Segment Reporting, Reconciling Item, Corporate Nonsegment Segment Reporting, Reconciling Item, Corporate Nonsegment [Member] Tax Return to Provision Effective Income Tax Rate Reconciliation, True-Up Adjustments, Amount Effective Income Tax Rate Reconciliation, True-Up Adjustments, Amount Granted (in dollars per share) Weighted Average Exercise Price, Warrants Granted Weighted Average Exercise Price, Warrants Granted Expected weighted-average period in years of compensation cost to be recognized Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Revenue Revenue from Contract with Customer, Excluding Assessed Tax ASCEND trial Ascend Trial [Member] Ascend Trial State and local State and Local Income Tax Expense (Benefit), Continuing Operations Total other income Nonoperating Income (Expense) Statement of Comprehensive Income [Abstract] Statement of Comprehensive Income [Abstract] New York New York State Division of Taxation and Finance [Member] Cash equivalents Cash Equivalents, at Carrying Value Number of terminated employee Number of Terminated Employee Number of Terminated Employee Auditor Firm ID Auditor Firm ID Effective tax rate Effective Income Tax Rate Reconciliation, Percent Net cash provided by investing activities Net Cash Provided by (Used in) Investing Activities Operating loss Operating Income (Loss) Income Tax Jurisdiction [Axis] Income Tax Jurisdiction [Axis] Australia Research and Development Tax Incentive Research and Development Tax Incentive [Text Block] Research and Development Tax Incentive Valuation allowance for deferred tax assets Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount Research and development Research and Development Expense (Excluding Acquired in Process Cost) Total liabilities, non-controlling interests and stockholders' equity Liabilities and Equity Subsequent Events Subsequent Events [Text Block] Rule 10b5-1 Arrangement Terminated Rule 10b5-1 Arrangement Terminated [Flag] All Adjustments to Compensation All Adjustments to Compensation [Member] Salaries, employee benefits and related taxes Employee-related Liabilities, Current Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Axis] Marketable Securities Marketable Securities, Policy [Policy Text Block] Prepaid and other current assets Increase (Decrease) in Prepaid Expense and Other Assets Additional paid-in capital Additional Paid in Capital Collaborative Arrangement and Arrangement Other than Collaborative [Table] Collaborative Arrangement and Arrangement Other than Collaborative [Table] Tax Credit Carryforward [Axis] Tax Credit Carryforward [Axis] Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Disclosure [Abstract] Legal Entity [Axis] Legal Entity [Axis] Exclusive License and Collaboration Agreement Exclusive License and Collaboration Agreement [Member] Exclusive License and Collaboration Agreement Underlying Security Market Price Change Underlying Security Market Price Change, Percent Limitation on NOL carryforwards Limitation on Net Operating Loss Carryforwards Limitation on Net Operating Loss Carryforwards Tax Credit Carryforward, Name [Domain] Tax Credit Carryforward, Name [Domain] Individual: Individual [Axis] Common stock outstanding Common Stock, Value, Outstanding Accumulated Other Comprehensive Loss AOCI Attributable to Parent [Member] Forfeited (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price Expected term (in years) Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term Valuation Assumptions Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology [Abstract] Product and Service [Axis] Product and Service [Axis] Entity Address, State or Province Entity Address, State or Province Property, Plant and Equipment [Line Items] Property, Plant and Equipment [Line Items] Statement [Line Items] Statement [Line Items] Erroneous Compensation Analysis Erroneous Compensation Analysis [Text Block] Basic and diluted loss per share: Earnings Per Share Basic and DIluted EPS [Abstract] Earnings Per Share Basic and DIluted EPS Operating Expenses: Operating Expenses [Abstract] Schedule of Property and Equipment Property, Plant and Equipment [Table Text Block] Compensation Actually Paid vs. Total Shareholder Return Compensation Actually Paid vs. Total Shareholder Return [Text Block] Financial Instruments [Domain] Financial Instruments [Domain] Vesting [Domain] Vesting [Domain] Beginning balance, Weighted average grant date fair value (in dollars per share) Ending balance, Weighted average grant date fair value (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value LIABILITIES, NON-CONTROLLING INTERESTS AND STOCKHOLDERS' EQUITY Liabilities and Equity [Abstract] Purchase price measurement as percent of closing price on enrollment date Employee Stock Purchase Plan, Purchase Price, Percent Of Closing Price On Enrollment Date Employee Stock Purchase Plan, Purchase Price, Percent Of Closing Price On Enrollment Date ESPP Employee Stock Purchase Plan [Member] Employee Stock Purchase Plan [Member] Investor relations/public relations/communications Communications and Information Technology Minimum Minimum [Member] Restatement Determination Date Restatement Determination Date Change in state deferred Effective Income Tax Rate Reconciliation, Change in State Deferred, Amount Effective Income Tax Rate Reconciliation, Change in State Deferred, Amount Options, vested or expected to vest (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number Variable consideration amounts, milestones Revenue, Remaining Performance Obligation, Variable Consideration Amount Revenue, Remaining Performance Obligation, Variable Consideration Amount Potential milestone payments Collaborative Arrangement, Rights and Obligations, Maximum Aggregate Milestone Payments, Per Product Collaborative Arrangement, Rights and Obligations, Maximum Aggregate Milestone Payments, Per Product Royalty Royalty [Member] Adoption Date Trading Arrangement Adoption Date Pay vs Performance Disclosure Pay vs Performance Disclosure [Table] Warrants exercisable, weighted average remaining contractual term (in years) weighted Average Remaining Contractual Term, warrants vested weighted Average Remaining Contractual Term, warrants vested Schedule of Available-for-Sale Securities Reconciliation Schedule of Available-for-Sale Securities Reconciliation [Table Text Block] Schedule of Property, Plant and Equipment [Table] Property, Plant and Equipment [Table] Outstanding, beginning balance (in dollars per share) Outstanding, ending balance (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Right-of-use assets Operating Lease, Right-of-Use Asset Erroneously Awarded Compensation Recovery Erroneously Awarded Compensation Recovery [Table] Outstanding, beginning balance (in shares) Outstanding, ending balance (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Segments [Axis] Segments [Axis] Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member] U.S. federal corporate income tax rate (percent) Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent Property, Plant and Equipment [Abstract] Property, Plant and Equipment [Abstract] Exercise Price Award Exercise Price Schedule of Components Deferred Income Taxes Schedule of Deferred Tax Assets and Liabilities [Table Text Block] Income (Loss) Per Share Earnings Per Share [Text Block] Arrangement Duration Trading Arrangement Duration Subsequent event Subsequent Event [Member] Net operating loss carryforwards Operating Loss Carryforwards Proceeds from option exercises Stock Issued During Period, Value, Stock Options Exercised Research tax credit rate Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent Stockholders' Equity Equity, Attributable to Parent [Abstract] Weighted average estimated fair value (in dollars per share) Granted, Weighted average grant date fair value (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Audit Information [Abstract] Audit Information Federal Domestic Tax Jurisdiction [Member] Warrants vested or expected to vest, aggregate intrinsic value Aggregate Intrinsic Value, Warrants Vested and Expected to Vest Aggregate Intrinsic Value, Warrants Vested and Expected to Vest Peer Group Issuers, Footnote Peer Group Issuers, Footnote [Text Block] Segment [Domain] Segments [Domain] Material Terms of Trading Arrangement Material Terms of Trading Arrangement [Text Block] Unrecognized Tax Benefits [Roll Forward] Unrecognized Tax Benefits [Roll Forward] All Individuals All Individuals [Member] PEO PEO [Member] Granted (in shares) Warrants Granted, Shares Warrants Granted, Shares Income Tax Disclosure [Abstract] Income Tax Disclosure [Abstract] Name Trading Arrangement, Individual Name Other expense, net Other income (expense),net Other Nonoperating Income (Expense) Percentage of net sale Revenue, Performance Obligation, Percentage of Net Sale Revenue, Performance Obligation, Percentage of Net Sale Intangible assets, net Intangible Assets, Net (Excluding Goodwill) Statement of Stockholders' Equity [Abstract] Statement of Stockholders' Equity [Abstract] Purchase price measurement as percent of closing price on exercise date Employee Stock Purchase Plan, Purchase Price, Percent Of Closing Price On Exercise Date Employee Stock Purchase Plan, Purchase Price, Percent Of Closing Price On Exercise Date Long-Lived Tangible Asset [Axis] Long-Lived Tangible Asset [Axis] Entity Public Float Entity Public Float Gross Unrealized Gains Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax Shares issued under license agreement (in shares) Shares Issued Under License Agreement Shares Issued Under License Agreement Loss from equity method investment Equity method investment expense Income (Loss) from Equity Method Investments Treasury stock, at cost; 738 shares at December 31, 2024 and December 31, 2023 respectively Treasury Stock, Common, Value Options, exercisable (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number Term of offering period Offering Periods, Employee Stock Purchase Plan, Term Offering Periods, Employee Stock Purchase Plan, Term Awards Close in Time to MNPI Disclosures, Table Awards Close in Time to MNPI Disclosures [Table Text Block] Share-based award tranche three Share-Based Payment Arrangement, Tranche Three [Member] Other true ups Effective Income Tax Rate Reconciliation, Other True-Up Adjustments, Amount Effective Income Tax Rate Reconciliation, Other True-Up Adjustments, Amount Assets: Assets, Fair Value Disclosure [Abstract] Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table] Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table] Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member] Cash equivalents Cash and Cash Equivalents, Fair Value Disclosure Aggregate Erroneous Compensation Amount Aggregate Erroneous Compensation Amount Local Phone Number Local Phone Number Valuation allowance Deferred Tax Assets, Valuation Allowance Aggregate Erroneous Compensation Not Yet Determined Aggregate Erroneous Compensation Not Yet Determined [Text Block] Operating expenses Operating Expenses Risk-free interest rate - maximum Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum Schedule of Restricted Stock Units Share-Based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block] Capitalized research and development Deferred Tax Assets, Capitalized Research And Development Deferred Tax Assets, Capitalized Research And Development Stock Options, Weighted Average Contractual Term and Intrinsic Value Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures [Abstract] Other assets Increase (Decrease) in Other Operating Assets Changes in operating assets and liabilities: Increase (Decrease) in Operating Capital [Abstract] PEO Total Compensation Amount PEO Total Compensation Amount U.S. Federal Deferred Federal Income Tax Expense (Benefit) Long-Lived Tangible Asset [Domain] Long-Lived Tangible Asset [Domain] Schedule of Accrued Liabilities Schedule of Accrued Liabilities [Table Text Block] Statement of Income Location, Balance [Axis] Statement of Income Location, Balance [Axis] Options, vested or expected to vest (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price Cash and Cash Equivalents Cash and Cash Equivalents, Policy [Policy Text Block] Contingencies Commitments and Contingencies Disclosure [Text Block] Common Stock Common Stock [Member] Measure: Measure [Axis] Qilu Qilu [Member] Qilu Additions based on tax positions related to the current year Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions Operating Loss Carryforwards [Table] Operating Loss Carryforwards [Table] Expired (in shares) Warrants Expired, Shares Warrants Expired, Shares Forgone Recovery due to Expense of Enforcement, Amount Forgone Recovery due to Expense of Enforcement, Amount Net proceeds from issuance of common stock (in shares) Stock issued (in shares) Stock Issued During Period, Shares, New Issues Revenue, Major Customer [Line Items] Revenue, Major Customer [Line Items] Entity Emerging Growth Company Entity Emerging Growth Company Right-of-use assets, balance sheet line item Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration] Segment Reporting [Abstract] Segment Reporting [Abstract] Warrants exercisable (in shares) Warrants, Vested Warrants, Vested Entity Central Index Key Entity Central Index Key General and administrative General and Administrative Expense [Member] Accrued Liabilities [Abstract] Accrued Liabilities [Abstract] Non-GAAP Measure Description Non-GAAP Measure Description [Text Block] Non-PEO NEO Average Compensation Actually Paid Amount Non-PEO NEO Average Compensation Actually Paid Amount Number of offering periods Number of Offering Periods, Employee Stock Purchase Plan Number of Offering Periods, Employee Stock Purchase Plan Expected volatility - minimum Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum Australian Taxation Office Australian Taxation Office [Member] Stockholders' Equity Equity [Text Block] Award Timing, How MNPI Considered Award Timing, How MNPI Considered [Text Block] Equity Component [Domain] Equity Component [Domain] Financial Instrument [Axis] Financial Instrument [Axis] Segment Information Segment Reporting Disclosure [Text Block] SAFE, discount rate SAFE, Discount Rate SAFE, Discount Rate Additional 402(v) Disclosure Additional 402(v) Disclosure [Text Block] Exercised (in shares) Warrants Exercised, Shares Warrants Exercised, Shares Share-based compensation APIC, Share-Based Payment Arrangement, Increase for Cost Recognition Restricted Stock Restricted Stock [Member] Entity Shell Company Entity Shell Company Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Other Research And Development, Other [Member] Research And Development, Other Title Trading Arrangement, Individual Title Statement [Table] Statement [Table] Litigation settlement, payment term Litigation Settlement, Payment Term Litigation Settlement, Payment Term Counterparty Name [Axis] Counterparty Name [Axis] Measurement Frequency [Domain] Measurement Frequency [Domain] Summary of Significant Accounting Policies Significant Accounting Policies [Text Block] Schedule of Benefit from Income Taxes Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block] Unrecognized tax benefits Gross unrecognized tax benefit, beginning of period Gross unrecognized tax benefit, end of period Unrecognized Tax Benefits Comprehensive income (loss) attributable to noncontrolling interests Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest Consolidation Items [Domain] Consolidation Items [Domain] City Area Code City Area Code Auditor Location Auditor Location Agency bonds Bonds [Member] Insider Trading Policies and Procedures Not Adopted Insider Trading Policies and Procedures Not Adopted [Text Block] Level 1 Fair Value, Inputs, Level 1 [Member] Cumulative translation adjustment arising during the period Foreign currency translation adjustment Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax Total current assets Assets, Current Statement of Cash Flows [Abstract] Statement of Cash Flows [Abstract] Legal Legal, General And Administrative Expense Legal, General And Administrative Expense Accrued payroll Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Employee Compensation Loss on sale of NOLs Loss On Sale Of Net Operating Losses Loss On Sale Of Net Operating Losses Marketable securities Marketable securities Marketable Securities Proceeds from sale of NOLs Proceeds From Sale Of Net Operating Losses Proceeds From Sale Of Net Operating Losses Weighted average estimated fair value of shares granted (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value Weighted-Average Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract] Operating loss carryforwards, post acquisition Operating Loss Carryforwards, Post Acquisition Operating Loss Carryforwards, Post Acquisition Entity Well-known Seasoned Issuer Entity Well-known Seasoned Issuer Subsequent Event Type [Axis] Subsequent Event Type [Axis] Income Taxes Income Tax Disclosure [Text Block] Earnings Per Share [Abstract] Earnings Per Share [Abstract] Permanent nondeductible expenses for U.S. taxes Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount Equity [Abstract] Equity [Abstract] Less - net income (loss) attributable to noncontrolling interests Income (Loss) from Continuing Operations, Net of Tax, Attributable to Noncontrolling Interest Estimated Fair Value Debt Securities, Available-for-Sale, Fair Value, Fiscal Year Maturity [Abstract] Accumulated deficit Retained Earnings (Accumulated Deficit) In-process Research and Development Expense In Process Research and Development, Policy [Policy Text Block] Outstanding, beginning balance (in dollars per share) Outstanding, ending balance (in dollars per share) Weighted Average Exercise Price, Warrants Outstanding Weighted Average Exercise Price, Warrants Outstanding General and administrative General and administrative General and Administrative Expense Litigation settlement, amount awarded to other party Litigation Settlement, Amount Awarded to Other Party Organization, Consolidation and Presentation of Financial Statements [Abstract] Organization, Consolidation and Presentation of Financial Statements [Abstract] Aggregate Available Trading Arrangement, Securities Aggregate Available Amount Equity Awards Adjustments Equity Awards Adjustments [Member] Weighted average discount rate for operating leases (percent) Operating Lease, Weighted Average Discount Rate, Percent Total Operating Lease Liabilities Present value of lease liabilities Operating Lease, Liability Net cash (used in) provided by financing activities Net Cash Provided by (Used in) Financing Activities Underlying Securities Award Underlying Securities Amount Available-for-Sale-Securities Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block] Income Taxes [Line Items] Operating Loss Carryforwards [Line Items] Amendment Flag Amendment Flag Entity Registrant Name Entity Registrant Name Loss on disposal of fixed assets Gain (Loss) on Disposition of Property Plant Equipment Lease liability Deferred Tax Assets, Right Of Use Liability Deferred Tax Assets, Right Of Use Liability Adjustment to Non-PEO NEO Compensation Footnote Adjustment to Non-PEO NEO Compensation Footnote [Text Block] Stock Appreciation Rights (SARs) Stock Appreciation Rights (SARs) [Member] State and local Deferred State and Local Income Tax Expense (Benefit) Fair Value as of Grant Date Award Grant Date Fair Value AUS Foreign Rate Differential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount Subsequent Events [Abstract] Subsequent Events [Abstract] Options vested or expected to vest, aggregate intrinsic value Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value Level 2 Fair Value, Inputs, Level 2 [Member] Less than one year Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One Fair Value Hierarchy and NAV [Domain] Fair Value Hierarchy and NAV [Domain] Recovery of Erroneously Awarded Compensation Disclosure [Line Items] Business development Business Development Net proceeds from issuance of common stock Stock Issued During Period, Value, New Issues Milestones and Royalties Collaborative Arrangement, Accounting Policy [Policy Text Block] Entity Address, Postal Zip Code Entity Address, Postal Zip Code Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Schedule of Share-Based Compensation Expense Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block] Principles of Consolidation Consolidation, Policy [Policy Text Block] Restatement Determination Date: Restatement Determination Date [Axis] Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Title of 12(b) Security Title of 12(b) Security Technology Transfer Agreement [Abstract] Technology Transfer Agreement Common stock, $0.001 par value, authorized 500,000,000 shares; issued 8,409,582 and 8,150,635 shares, at December 31, 2024 and December 31, 2023, respectively; and outstanding, 8,408,844 and 8,149,897 shares, at December 31, 2024 and December 31, 2023, respectively Common Stock, Value, Issued Document Financial Statement Error Correction Flag Document Financial Statement Error Correction [Flag] Share-based Payment Arrangement [Abstract] Share-Based Payment Arrangement [Abstract] Income Tax Authority, Name [Domain] Income Tax Authority, Name [Domain] Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value Schedule of Investments [Table] Schedule of Investments [Table] Incremental stock-based compensation expense Share-Based Payment Arrangement, Incremental Expense Share-Based Payment Arrangement, Incremental Expense Kuva Kuva [Member] Kuva Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member] Options exercisable, aggregate intrinsic value Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value Auditor Name Auditor Name Other Deferred Tax Assets, Other Impilo Impilo [Member] Impilo Forfeited, Weighted average grant date fair value (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value Current Current Income Tax Expense (Benefit), Continuing Operations [Abstract] Maximum annual contribution per employee as percent of annual salary Employee Stock Purchase Plan, Maximum Annual Contribution Per Employee, Percent Employee Stock Purchase Plan, Maximum Annual Contribution Per Employee, Percent Cash flows from financing activities: Net Cash Provided by (Used in) Financing Activities [Abstract] Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member] Operating lease liabilities, current, balance sheet line item Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration] Useful life (in years) Property, Plant and Equipment, Useful Life Stock Options, Shares Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward] Deferred tax liabilities Deferred Tax Liabilities, Gross Depreciation and amortization Depreciation, Depletion and Amortization, Nonproduction Lisata Therapeutics, Inc. common stockholders - basic (in dollars per share) Earnings Per Share, Basic Expired options Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-Based Payment Arrangement, Amount Net proceeds from issuance of common stock Proceeds from Issuance of Common Stock Income Tax Holiday [Line Items] Income Tax Holiday [Line Items] Adjustment To PEO Compensation, Footnote Adjustment To PEO Compensation, Footnote [Text Block] Award Timing MNPI Disclosure Award Timing MNPI Disclosure [Text Block] Expiration period (in years) Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period Aggregate Pension Adjustments Service Cost Aggregate Pension Adjustments Service Cost [Member] Property and Equipment Property, Plant and Equipment, Policy [Policy Text Block] Compensation Actually Paid vs. Other Measure Compensation Actually Paid vs. Other Measure [Text Block] Total current liabilities Liabilities, Current Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member] Total assets Assets Concentration of Risks Concentration Risk, Credit Risk, Policy [Policy Text Block] Weighted average volatility Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate Amortization expense, year one Finite-Lived Intangible Asset, Expected Amortization, Year One Granted (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period Schedule of Fair Value of Assets Measured on Recurring Basis Fair Value, Assets Measured on Recurring Basis [Table Text Block] Other long-term liabilities Other Liabilities, Noncurrent Forgone Recovery due to Violation of Home Country Law, Amount Forgone Recovery due to Violation of Home Country Law, Amount Commitments and Contingencies (Note 14) Commitments and Contingencies Share-Based Compensation Share-Based Payment Arrangement [Policy Text Block] Risk-free interest rate - minimum Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum Expired (in dollars per share) Weighted Average Exercise Price, Warrants Expired Weighted Average Exercise Price, Warrants Expired Schedule of Reconciliation of Effective Income Taxes Schedule of Effective Income Tax Rate Reconciliation [Table Text Block] Termination Date Trading Arrangement Termination Date Expected volatility - maximum Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum Description of Business Business Description and Basis of Presentation [Text Block] Finance Finance, General And Administrative Expense Finance, General And Administrative Expense Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Share-Based Compensation Share-Based Payment Arrangement [Text Block] Entity Address, City or Town Entity Address, City or Town Deferred Tax Assets: Deferred Tax Assets, Gross [Abstract] Greater than one year Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five Leases Lessee, Leases [Policy Text Block] Schedule of Stock Options and Warrants Activity Share-Based Payment Arrangement, Option, Activity [Table Text Block] Total share-based compensation expense Share-Based Payment Arrangement, Expense Revenue from collaborative arrangement Revenue Revenue from Collaborative Arrangement, Excluding Revenue from Contract with Customer Net loss attributable to Lisata Therapeutics, Inc. common stockholders Net Income (Loss) Net Income (Loss) Attributable to Parent Trading Arrangement: Trading Arrangement [Axis] Investments, Debt and Equity Securities [Abstract] Investments, Debt and Equity Securities [Abstract] Outstanding, beginning balance (in shares) Outstanding, ending balance (in shares) Common Stock Warrants, Shares Common Stock Warrants, Shares Granted (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Pay vs Performance Disclosure, Table Pay vs Performance [Table Text Block] Loss Contingencies [Table] Loss Contingencies [Table] Forfeited (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period Equity Awards Adjustments, Excluding Value Reported in Compensation Table Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member] Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member] Share based compensation expense Share Based Compensation Expense, General And Administrative Expense Share Based Compensation Expense, General And Administrative Expense Foreign Tax Jurisdiction Foreign Tax Jurisdiction [Member] Entity File Number Entity File Number Reportable Segment Reportable Segment [Member] Reportable Segment Percentage of sublicensing revenues Revenue, Performance Obligation, Percentage of Sublicensing Revenues Revenue, Performance Obligation, Percentage of Sublicensing Revenues Document Fiscal Year Focus Document Fiscal Year Focus Non- Controlling Interest in Subsidiary Noncontrolling Interest [Member] Income Statement [Abstract] Income Statement [Abstract] Entity Address, Address Line One Entity Address, Address Line One U.S. Federal Current Federal Tax Expense (Benefit) Weighted average common shares outstanding: Weighted Average Number of Shares Outstanding Reconciliation [Abstract] Income tax incentive receivable Income Tax Incentive Receivable Income Tax Incentive Receivable Effect of exchange rate changes on cash Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations Other Other Accrued Liabilities, Current Assets, fair value Assets, Fair Value Disclosure Name Forgone Recovery, Individual Name Australia Income (Loss) from Continuing Operations before Income Taxes, Foreign Warrants outstanding, aggregate intrinsic value Aggregate Intrinsic Value, Warrants Outstanding Aggregate Intrinsic Value, Warrants Outstanding Weighted average remaining lease term for operating leases (in years) Operating Lease, Weighted Average Remaining Lease Term Document Period End Date Document Period End Date Subsidiary, Sale of Stock [Axis] Sale of Stock [Axis] Number of offices under operating leases Number Of Offices Under Operating Leases Number Of Offices Under Operating Leases Award Timing MNPI Considered Award Timing MNPI Considered [Flag] Total lease payments Lessee, Operating Lease, Liability, to be Paid Beginning balance (in shares) Ending balance (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number Expired (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expirations in Period Insider Trading Arrangements [Line Items] New Jersey New Jersey Division of Taxation [Member] Outstanding Aggregate Erroneous Compensation Amount Outstanding Aggregate Erroneous Compensation Amount Annual license maintenance fee, year seven Collaborative Arrangement, Rights and Obligations, Annual License Maintenance Fee Starting at Year Seven Collaborative Arrangement, Rights and Obligations, Annual License Maintenance Fee Starting at Year Seven PEO Actually Paid Compensation Amount PEO Actually Paid Compensation Amount Amortized Cost Debt Securities, Available-for-Sale, Amortized Cost, Fiscal Year Maturity [Abstract] Schedule of Marketable Securities Marketable Securities [Table Text Block] Adjustment to Compensation: Adjustment to Compensation [Axis] ATM Agreement At The Market Offering Agreement [Member] At The Market Offering Agreement Prepaid and other current assets Prepaid Expense and Other Assets, Current Warrants outstanding, weighted average remaining contractual term (in years) Weighted Average Remaining Contractual Term warrant outstanding Weighted Average Remaining Contractual Term warrant outstanding Document Transition Report Document Transition Report Schedule of Revenue by Major Customers, by Reporting Segments [Table] Schedule of Revenue by Major Customers, by Reporting Segments [Table] Greater than one year Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year One Through Five Schedule of Unrecognized Tax Benefits Roll Forward Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block] Investment in Impilo Therapeutics Payments to acquire Impilo SAFE Payments to Acquire Other Investments Shares canceled (in shares) Investment Owned, Canceled, Shares Investment Owned, Canceled, Shares Litigation Case [Domain] Litigation Case [Domain] Fair Value, Recurring and Nonrecurring [Table] Fair Value, Recurring and Nonrecurring [Table] Accumulated other comprehensive loss Accumulated Other Comprehensive Income (Loss), Net of Tax Entity Current Reporting Status Entity Current Reporting Status Accumulated Deficit Retained Earnings [Member] Pension Adjustments Service Cost Pension Adjustments Service Cost [Member] Income Tax Authority, Name [Axis] Income Tax Authority, Name [Axis] Basic (in shares) Weighted Average Number of Shares Outstanding, Basic Stock Price or TSR Estimation Method Stock Price or TSR Estimation Method [Text Block] Total equity Beginning Balance Ending Balance Equity, Including Portion Attributable to Noncontrolling Interest Restricted stock units Restricted Stock Units (RSUs) [Member] Treasury Stock Stockholders' Equity, Policy [Policy Text Block] Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Components of Deferred Tax Assets and Liabilities [Abstract] Components of Deferred Tax Assets and Liabilities [Abstract] Amended 2017 ESPP Employee Stock Purchase Plan 2017 Amended [Member] Employee Stock Purchase Plan 2017 Amended [Member] Accounting & tax consulting liabilities Accrued Professional Fees, Current Executive Category: Executive Category [Axis] Name Awards Close in Time to MNPI Disclosures, Individual Name Forfeited (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period Clinical and R&D related liabilities Clinical and Research And Development Related Liabilities, Current Clinical and Research And Development Related Liabilities, Current Schedule of Provision for Income Taxes Based on Loss from Operations Schedule of Components of Income Tax Expense (Benefit) [Table Text Block] Entity Filer Category Entity Filer Category Total fair value of shares vested Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested in Period, Fair Value Operating loss carryforwards, subject to expiration Deferred Tax Assets, Operating Loss Carryforwards, Subject to Expiration Statement of Income Location, Balance [Domain] Statement of Income Location, Balance [Domain] Loss Contingencies [Line Items] Loss Contingencies [Line Items] Company Selected Measure Name Company Selected Measure Name